Breaks Categories: Analyst Alerts

FridayFeb 03, 2017 12:18 pm

NetworkNewsBreaks – Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) Prices $3.6M Public Offering; Shares Tumble

Shares of Interpace Diagnostics Group (NASDAQ: IDXG) are 25% lower in late morning trade after the company priced its public offering of 1.2 million shares of common stock at $3 per share for estimated gross proceeds of approximately $3.6 million. Additionally, the company has permitted the representative of the underwriters an over-allotment option to purchase up to an additional 108,000 shares of its common stock. Interpace said it intends to use the net proceeds of the offering for working capital, repayment of debt and other liabilities, and general corporate purposes. Pending customary closing conditions, the offering is expected to close…

Continue Reading

ThursdayFeb 02, 2017 12:24 pm

NetworkNewsBreaks – NV5 Global, Inc. (NASDAQ: NVEE) Surpasses Revenue Goals; Secures over $10M in Contracts

NV5 Global (NASDAQ: NVEE) kicked-off 2017 with news that it had surpassed its goal to enter into the New Year with $300 million in annual revenues. The company intends to reach $600 million in annual revenues by 2020, and it was recently awarded over $10 million in contracts with U.S. airports. In addition to a $5 million contract with Dallas Fort Worth International Airport to provide retro commissioning, infrastructure asset condition assessment and other services to modernize the airport's asset portfolio over five years, NV5 was awarded a $5.4 million contract to provide quality assurance testing services at Fort Lauderdale…

Continue Reading

WednesdayFeb 01, 2017 1:36 pm

NetworkNewsBreaks – NAPCO Security Technologies, Inc. (NASDAQ: NSSC) Responds to Changing Security Demands, Successfully Grows Top and Bottom Lines

NAPCO Security Technologies (NASDAQ: NSSC), a worldwide manufacturer of various security products, is developing advanced technologies for intrusion, fire, video, wireless, access control and door locking systems for commercial, industrial, institutional, residential and government application. Founded in 1969, the company has a track record of evolution on pace with the changing market for security solutions. Taking advantage of the growing demand for connected home products and alarm systems compatible with 3G cellular networks, NAPCO has launched several new products designed to provide recurring revenue streams and further solidify the company’s position in the broader security market. The company has consistently…

Continue Reading

TuesdayJan 31, 2017 2:29 pm

NetworkNewsBreaks – Ocera Therapeutics (NASDAQ: OCRX) Steady with ‘Buy’ Rating, but Lower PT Following OCR-002 Top Line Results

Maintaining a ‘Buy’ rating on Ocera Therapeutics (NASDAQ: OCRX), Aegis Capital has lowered its price target on the company’s stock to $3 from $8. Ocera yesterday reported top-line results from its exploratory STOP-HE phase 2b study of OCR-002 in hospitalized patients with hepatic encephalopathy (HE). OCR-002 missed its primary endpoint, though results show dose-dependent clinical improvement. “The patients at the higher doses (15 and 20 grams) had faster clinical improvement and greater complete response rates compared to the patients on the lowest dose (10 grams) and those on placebo. These findings will be integral in determining dose levels for future…

Continue Reading

TuesdayJan 31, 2017 11:43 am

NetworkNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Positioned for Growth in $68.71B Market

Moxian, an offline-online (O2O) integrated platform operator, is set for growth in the booming O2O market. “Moxian, Inc. (NASDAQ: MOXC) is positioning itself as a leader in China’s O2O services market as the sector enjoys a 20% surge in year-over-year growth. iResearch Consulting Group, in its ‘2015 China Online-to-Offline (O2O) Services Model Research' … stated that the Chinese O2O market was on course to grow from $53.78 billion in 2015, to $68.71 billion in 2016. The report also forecast growth of 20% year-over-year through 2018 to more than $90 billion (http://nnw.fm/Jyj1C).” To view the full article, visit: http://nnw.fm/8XRdU About Moxian,…

Continue Reading

WednesdayJan 25, 2017 9:56 am

NetworkNewsBreaks – Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) Takes Aim at Lucrative $7.5B U.S. Dermatology Market

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA), formally Oculus Innovative Sciences, is an international scientific health care company focused on providing treatment solutions for dermatological conditions. Dermatological conditions are some of the most prevalent health problems internationally, collectively surpassing the commonness of conditions such as obesity, hypertension and cancer. In the United States alone, the market for skin disease treatment totaled $7.5 billion in 2015 and is estimated to reach $8.6 billion in 2020. The global market for skin disease treatment technologies, which reached $17.1 billion in 2015, is estimated to reach $20.4 billion in 2020, demonstrating a five-year CAGR of 3.6%.…

Continue Reading

TuesdayJan 24, 2017 9:37 am

NetworkNewsBreaks – Chanticleer Holdings, Inc. (NASDAQ: HOTR) Sets Steady Pace for Continued Corporate Expansion

Founded in 2005, Chanticleer Holdings (NASDAQ: HOTR) employed a strategically phased growth plan to become the current owner, operator and franchisor of several award-winning regional fast casual brands such as little big burger®, The Burger Joint, American Burger Co., Just Fresh, and Hooters. On par with this growth, the company has steadily increased annual revenues from $1.5 million in 2011 to $43.9 million as of the third quarter of 2016. Chanticleer’s growth strategy remains active, with a goal to accelerate growth and franchising, and, by the year 2020, double its store count to 110-140; increase revenues to between $100 million…

Continue Reading

MondayJan 23, 2017 2:01 pm

NetworkNewsBreaks – U.S. Geothermal, Inc. (NYSE: HTM) Reaffirms 2016 Guidance, Offers Outlook for 2017

U.S. Geothermal (NYSE MKT: HTM) is a renewable energy company on a mission to become the largest pure play independent geothermal power producer, targeting 135 MW by 2021 and a market cap in excess of $1 billion. With the U.S. market demand for electricity rising and creating a growing dependency on non-renewable, non-sustainable resources, U.S. Geothermal plans to accomplish this goal by remaining focused on the development, production and sale of electricity from geothermal energy. The company has confirmed its 2016 guidance for adjusted earnings of $4 million-$8 million on revenues between $29 million-$34 million; for FY17, U.S. Geothermal said…

Continue Reading

FridayJan 20, 2017 12:22 pm

NetworkNewsBreaks – Advanced Medical Isotope Corp. (ADMD) Targets Cancer, $1B Market with Brachytherapy Devices

Advanced Medical Isotope (OTC: ADMD) (“AMI”) develops cutting-edge brachytherapy devices for therapeutic applications, such as the Y-90 RadioGel™ device. Brachytherapy is the use of radiation to destroy cancerous tumors by placing a radiation source inside or next to the treatment area. AMI is in a booming industry, with the estimated annual sales of brachytherapy products exceeding $1 billion, about half of which are attributed to the United States. In October, the company reported that the first family pet, a cat, was treated for cancer with the company's pet version of the Y-90 RadioGel™ device. The study outcome data will be…

Continue Reading

WednesdayJan 18, 2017 10:45 am

NetworkNewsBreaks – Aegis Reiterates ‘Buy’ Rating for Xtant Medical Holdings, Inc. (NYSE: XTNT) following 2016 Preliminary Results, Guidance for 2017

Noting two quarters of double-digit growth, Aegis Capital has reiterated its 'Buy' rating and $3.50 price target for Xtant Medical (NYSE MKT: XTNT). Xtant Friday reported preliminary fourth quarter 2016 revenues of at least $24.5 million, an increase of 10% compared to the year ago quarter, and in line with Aegis estimates of $24.6 million. Adjusted EBITDA for the fourth quarter is expected to be at least $1.25 million vs a loss of $350,000 in the fourth quarter of 2015, shy of Aegis’ estimates of $1.5 million. Xtant estimates full-year 2016 revenue of at least $90 million, up 4.1% compared…

Continue Reading